Dermata Therapeutics, Inc.
USD1.28
-0.02 (-1.54%)
CEO
Gerald T. Proehl
IPO Date
2021-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.27
Prev. Close
$1.30
Day Low
$1.25
Day High
$1.33
52W Low
$1.10
52W High
$8.00
Market Cap
$0.00B
Volume
0.14M
| 1,000 |
| $1.27 |
| 6 Jan 2026 | PROEHL GERALD T | director, 10 percent owner, officer: President, CEO and Chairman | A-Award | Acquired | 37,500 | $2.18 |
| 6 Jan 2026 | WIERENGA WENDELL | director | A-Award | Acquired | 2,500 | $2.18 |
| 6 Jan 2026 | HALE DAVID F | director | A-Award | Acquired | 2,500 | $2.18 |
| 6 Jan 2026 | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | A-Award | Acquired | 9,000 | $2.18 |
| 6 Jan 2026 | Scott Kathleen D. | director | A-Award | Acquired | 2,500 | $2.18 |
| 6 Jan 2026 | Nardo Christopher J. | Senior VP, CDO | A-Award | Acquired | 18,000 | $2.18 |
| 6 Jan 2026 | Sandler Andrew Seth | director | A-Award | Acquired | 2,500 | $2.18 |
| 6 Jan 2026 | Van Hoose Kyri K. | SVP, CFO | A-Award | Acquired | 18,000 | $2.18 |